Literature DB >> 2257234

Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids.

R B Dickson1, E W Thompson, M E Lippman.   

Abstract

Endogenous ovarian estrogens and progestins appear to play a critical role in the development and progression of breast cancer. Local productions of growth factors probably also contribute to malignant proliferation, while production and activation of collagenolytic enzymes may be equally critical for local invasive processes. The current review focuses on characterization of growth factor-receptor systems operant in normal and malignant breast epithelium. In addition, the determinants of local invasion are reviewed: attachment, modality, and proteose secretion. Finally, data are discussed concerning the regulation of both proliferation and invasion by hormones and antihormonal agents in hormone-dependent breast cancer. The results suggest new potential pharmacologic targets to explore to suppress onset and progression of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257234     DOI: 10.1016/0960-0760(90)90479-5

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  9 in total

Review 1.  Solving the puzzle of hormone-dependent breast cancer.

Authors:  R J Santen
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

Review 2.  Sex and the developing brain: suppression of neuronal estrogen sensitivity by developmental androgen exposure.

Authors:  N J MacLusky; D A Bowlby; T J Brown; R E Peterson; R B Hochberg
Journal:  Neurochem Res       Date:  1997-11       Impact factor: 3.996

Review 3.  The complexities of obesity and diabetes with the development and progression of pancreatic cancer.

Authors:  Bin Bao; Zhiwei Wang; Yiwei Li; Dejuan Kong; Shadan Ali; Sanjeev Banerjee; Aamir Ahmad; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-12-01

4.  The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.

Authors:  Paul A Foster; L W Lawrence Woo; Barry V L Potter; Michael J Reed; Atul Purohit
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

5.  Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells.

Authors:  A Tanaka; K Miyamoto; N Minamino; M Takeda; B Sato; H Matsuo; K Matsumoto
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

Review 6.  Aromatase inhibitors--mechanisms for non-steroidal inhibitors.

Authors:  H V Vanden Bossche; H Moereels; L M Koymans
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

7.  Effects of celecoxib and ly117018 combination on human breast cancer cells in vitro.

Authors:  Klaus H Baumann; Elmar Klusmeier; Isabel Eggemann; Silke Reinartz; Achim Almeroth; Mathias Kalder; Uwe Wagner
Journal:  Breast Cancer (Auckl)       Date:  2009-04-07

8.  Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155).

Authors:  M R Fielden; I Chen; B Chittim; S H Safe; T R Zacharewski
Journal:  Environ Health Perspect       Date:  1997-11       Impact factor: 9.031

9.  Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.

Authors:  R R Perry; Y Kang; B R Greaves
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.